Camlin Fine Science Q1 Results Review - Suffering Amid The Industry Headwinds: Nirmal Bang

Nirmal Bang Report

Camlin Fine Science Ltd. Q1 FY25 earnings performance came significantly below our estimates on account of industry headwinds such as subdued demand and China dumping. As a result, the company reported net loss of Rs 340 million during the quarter.

Among the product segments, only blends business reported growth on a QoQ basis (17% YoY). Vanillin is yet in the scale up mode and pricing pressure continues.

While the management has not changed its guidance of Rs 2 billion, Ebitda for FY25, anticipating better growth in H2, taking cognisance of the Q1 FY25 result and the overall commentary by peers, we have cut our earnings.

We believe that Camlin Fine Science earnings and return ratios can improve only if the overall pricing scenario improves and the company executes well on Vanillin, potential MPP at Italy.

Downgrade to Acc with a revised target price of Rs 110 after rolling forward valuation to June 2026E (15 times price to earning)

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.